We spend billions each year to research possible cures for type I diabetes, but the cure may already be on the shelf. Join host Dr. Bruce Bloom and his guest, Dr. Denise L. Faustman, associated professor of medicine at Harvard Medical School and director of the Immunobiology Laboratories at Massachusetts General Hospital, as they explore the first clinical trial using generic drugs to try to cure type I diabetes.
Do We Already Have the Cure for Type 1 Diabetes?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
We spend billions each year to research possible cures for type I diabetes, but the cure may already be on the shelf. Join host Dr. Bruce Bloom and his guest, Dr. Denise L. Faustman, associated professor of medicine at Harvard Medical School and director of the Immunobiology Laboratories at Massachusetts General Hospital, as they explore the first clinical trial using generic drugs to try to cure type I diabetes.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Updates From the 7th World Symposium Task Force
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?